Vitamin D in infants with cystic fibrosis diagnosed by newborn screening

Liza A Neville1, Sarath C Ranganathan

  • 1Department of Respiratory Medicine, Royal Children's Hospital, Melbourne Vic., Australia.

Insights

Vitamin D deficiency is common in infants with cystic fibrosis (CF) at diagnosis. Supplementation improves vitamin D levels over time, though initial deficiencies in vitamins A and E are linked to pancreatic insufficiency.

Area of Science:

  • Pediatric Nutrition
  • Cystic Fibrosis Research
  • Nutritional Biochemistry

Background:

  • Newborn screening identifies infants with cystic fibrosis (CF), enabling early detection of nutritional deficiencies.
  • While vitamin E deficiency is rare in older CF patients, vitamin D status at diagnosis and its relation to other fat-soluble vitamins are not well-established.

Purpose of the Study:

  • To determine vitamin D status in infants diagnosed with CF via newborn screening.
  • To investigate the relationship between vitamin D levels and other fat-soluble vitamins (A and E), sex, birth month, and pancreatic status at diagnosis.

Main Methods:

  • Retrospective review of vitamin levels in infants diagnosed with CF over a 5-year period.
  • Measurement of vitamin D using radioimmunoassay and vitamins A and E using high-performance liquid chromatography.
  • Statistical assessment of associations between vitamin D levels and demographic/clinical factors.

Main Results:

  • Of 58 infants diagnosed, 30 had initial vitamin D levels assessed. Deficiencies were noted in 37% for vitamin D, 16% for vitamin E, and 60% for vitamin A.
  • Vitamin D levels were not associated with sex, birth month, or pancreatic status, but were unrelated to vitamin A or E levels.
  • Infants with pancreatic insufficiency had significantly lower vitamin A and E levels. Vitamin D levels improved with supplementation over time.

Conclusions:

  • Vitamin D deficiency is prevalent in infants newly diagnosed with CF via newborn screening.
  • Initial vitamin D deficiency is not linked to pancreatic status or low vitamin E levels.
  • Vitamin D levels improve with treatment, indicating the effectiveness of supplementation strategies.
Abstract

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...